Myo, E., & Mohandas, C. (2025). Comparison of subcutaneous GLP-1 receptor agonists, semaglutide and dulaglutide, on HbA1c and weight loss outcomes: A systematic review. Advanced Journal of Professional Practice, 5(1), 45–46. https://doi.org/10.22024/UniKent/03/ajpp.1365